Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR2E1 | Q9Y466 | 1/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | TP53 | P04637 | 1/20 | 0.54 |
| ▸ | HPGD | P15428 | 1/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.54 |
| ▸ | RB1 | P06400 | 2/20 | 0.52 |
| ▸ | HTR2A | P28223 | 1/20 | 0.51 |
| ▸ | HTR2C | P28335 | 1/20 | 0.51 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.50 |
| ▸ | DRD1 | P21728 | 2/20 | 0.49 |
| ▸ | DRD5 | P21918 | 2/20 | 0.49 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.49 |
| ▸ | DRD2 | P14416 | 1/20 | 0.49 |
| ▸ | DRD4 | P21917 | 1/20 | 0.49 |
| ▸ | DRD3 | P35462 | 1/20 | 0.49 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7119213 | 0.89 | HPGD (0.68) | NR2E1KMT2AMEN1TP53HPGD | |
| SCHEMBL8579183 | 0.87 | RB1 (0.63) | NR2E1TP53HPGDHSD17B10RB1 | |
| SCHEMBL11076324 | 0.84 | NR2E1 (0.54) | NR2E1KMT2AMEN1HPGDHSD17B10 | |
| SCHEMBL23875668 | 0.82 | NR2E1 (0.65) | NR2E1TP53HPGDHSD17B10RB1 | |
| SCHEMBL8528531 | 0.81 | NR2E1 (0.63) | NR2E1TP53HPGDHSD17B10RB1 | |
| SCHEMBL4288282 | 0.80 | NR2E1 (0.67) | NR2E1TP53HPGDHSD17B10RB1 | |
| SCHEMBL21900686 | 0.80 | NR2E1 (0.67) | NR2E1TP53HPGDHSD17B10RB1 | |
| SCHEMBL21754250 | 0.80 | NR2E1 (0.67) | NR2E1TP53HPGDHSD17B10RB1 | |
| SCHEMBL700531 | 0.80 | NR2E1 (1.00) | NR2E1TP53HPGDHSD17B10RB1 | |
| SCHEMBL833503 | 0.80 | NR2E1 (1.00) | NR2E1TP53HPGDHSD17B10RB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021145729-A1 | NOVEL COMPOUND, PREPARATION METHOD THEREOF, AND USE THEREOF | DAEGU-GYEONGBUK MEDICAL INNOVATION FOUNDATION (KR) | 2021-07-22 | — | — | WO | disclosed |
| US-9159929-B2 | Rigid amines | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2015-10-13 | — | — | US | disclosed |
| US-20130220422-A1 | RIGID AMINES | CDT OXFORD LIMITED (GB) | 2013-08-29 | — | — | US | disclosed |
| US-8415029-B2 | Conjugated polymers prepared from rigid amines | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2013-04-09 | — | — | US | disclosed |
| WO-2013012297-A1 | NOVEL ORGANIC ELECTROLUMINESCENCE COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) | 2013-01-24 | — | — | WO | disclosed |
| US-8034882-B2 | Biscarbazol-9-yl-substituted triarylamine-containing polymers and electronic devices | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-10-11 | — | — | US | disclosed |
| US-20090270414-A1 | 2,3,4,9- TETRAHYDRO-1H-CARBAZOLE DERIVATIVES AS CRTH2 RECEPTOR ANTAGONISTS | ACTELION PHARMACEUTICALS LTD. (CH) | 2009-10-29 | — | — | US | disclosed |
| US-20090206731-A1 | Rigid Amines | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2009-08-20 | — | — | US | disclosed |
| US-20090066224-A1 | DICARBAZOLE AROMATIC AMINE POLYMERS AND ELECTRONIC DEVICES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-03-12 | — | — | US | disclosed |
| US-20080265755-A1 | Biscarbazol-9-Yl-Substituted Triarylamine-Containing Polymers and Electronic Devices | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2008-10-30 | — | — | US | disclosed |
| WO-2006096399-A2 | DICARBAZOLE AROMATIC AMINE POLYMERS AND ELECTRONIC DEVICES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2006-09-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090066224-A1 | DICARBAZOLE AROMATIC AMINE POLYMERS AND ELECTRONIC DEVICES | NAT1, SAT1, RIF1 | NR2E1 76/4885KMT2A 887/4885MEN1 864/4885 |
| US-20090270414-A1 | 2,3,4,9- TETRAHYDRO-1H-CARBAZOLE DERIVATIVES AS CRTH2 RECEPTOR ANTAGONISTS | HRH2, CRHR2, GRK2 | NR2E1 117/4885KMT2A 3465/4885MEN1 3762/4885 |
| US-20090206731-A1 | Rigid Amines | PARP3, H1-3, H1-2 | NR2E1 407/4885KMT2A 204/4885MEN1 1165/4885 |
| US-20080265755-A1 | Biscarbazol-9-Yl-Substituted Triarylamine-Containing Polymers and Electronic Devices | PYM1, KCNMB4, BRD9 | NR2E1 2449/4885KMT2A 823/4885MEN1 1308/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.